Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Raxibacumab - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for raxibacumab
Suppliers: see list2
Recent Clinical Trials: See clinical trials for raxibacumab
Recent Clinical Trials for raxibacumab

Identify potential brand extensions & biosimilar entrants

GlaxoSmithKlinePhase 4
GlaxoSmithKlinePhase 3
Human Genome Sciences Inc., a GSK CompanyPhase 3

See all raxibacumab clinical trials

Pharmacology for raxibacumab

Patent Text Search: US Patents for raxibacumab

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.